Characteristic . | Glimepiride . | Glipizide . | Glyburide . | Missing . |
---|---|---|---|---|
Entire cohort | ||||
Age (years) | 65.6 ± 13.1 | 66.1 ± 13.3 | 67.8 ± 13.1 | 0.0 |
BMI (kg/m2) | 31.1 ± 6.5 | 30.8 ± 6.8 | 30.8 ± 6.7 | 49.7 |
Systolic blood pressure (mmHg) | 134.8 ± 20.8 | 135.1 ± 21.8 | 135.9 ± 22.1 | 24.5 |
Diastolic blood pressure (mmHg) | 75.8 ± 11.6 | 75.4 ± 11.8 | 74.9 ± 11.8 | 24.5 |
HDL (mg/dl) | 45.4 ± 14.4 | 45.6 ± 14.2 | 45.9 ± 15.4 | 56.0 |
LDL (mg/dl) | 105.3 ± 36.4 | 107.0 ± 39.5 | 106.7 ± 39.4 | 57.5 |
Triglycerides (mg/dl) | 205.8 ± 225.1 | 204.4 ± 193.5 | 192.0 ± 170.9 | 56.5 |
A1C (%) | 7.5 ± 1.8 | 7.7 ± 1.9 | 7.6 ± 1.8 | 54.5 |
MDRD eGFR truncated at 90 | 71.2 ± 20.1 | 70.5 ± 20.9 | 69.8 ± 20.3 | 32.1 |
Zip median income ($) | 46,216.0 ± 14,888.5 | 43,786.1 ± 14,737.8 | 43,477.7 ± 14,583.6 | 0.1 |
Patients with CAD | ||||
Age (years) | 68.8 ± 11.2 | 70.3 ± 10.8 | 71.2 ± 10.3 | 0 |
BMI (kg/m2) | 30.2 ± 6.0 | 29.9 ± 6.0 | 30.3 ± 6.4 | 41.2 |
Systolic blood pressure (mmHg) | 133.4 ± 21.4 | 130.6 ± 22.1 | 132 ± 23.7 | 12.6 |
Diastolic blood pressure (mmHg) | 73.3 ± 11.7 | 71.6 ± 11.6 | 71.9 ± 11.7 | 12.7 |
HDL (mg/dl) | 43.7 ± 12.9 | 43.4 ± 13.2 | 44.2 ± 14.4 | 34.0 |
LDL (mg/dl) | 90.2 ± 35.6 | 93.9 ± 39.8 | 96.0 ± 36.7 | 35.0 |
Triglycerides (mg/dl) | 194.8 ± 256.2 | 203.6 ± 195.0 | 191.5 ± 191.0 | 35.0 |
A1C (%) | 7.3 ± 1.4 | 7.5 ± 1.6 | 7.3 ± 1.5 | 44.1 |
MDRD eGFR truncated at 90 | 64.9 ± 20.9 | 66.5 ± 20.9 | 62.7 ± 21.1 | 17.9 |
Zip median income ($) | 47,551.4 ± 15,925.4 | 44,756.9 ± 15,225.5 | 44,871.9 ± 15,716.3 | 0.1 |
Characteristic . | Glimepiride . | Glipizide . | Glyburide . | Missing . |
---|---|---|---|---|
Entire cohort | ||||
Age (years) | 65.6 ± 13.1 | 66.1 ± 13.3 | 67.8 ± 13.1 | 0.0 |
BMI (kg/m2) | 31.1 ± 6.5 | 30.8 ± 6.8 | 30.8 ± 6.7 | 49.7 |
Systolic blood pressure (mmHg) | 134.8 ± 20.8 | 135.1 ± 21.8 | 135.9 ± 22.1 | 24.5 |
Diastolic blood pressure (mmHg) | 75.8 ± 11.6 | 75.4 ± 11.8 | 74.9 ± 11.8 | 24.5 |
HDL (mg/dl) | 45.4 ± 14.4 | 45.6 ± 14.2 | 45.9 ± 15.4 | 56.0 |
LDL (mg/dl) | 105.3 ± 36.4 | 107.0 ± 39.5 | 106.7 ± 39.4 | 57.5 |
Triglycerides (mg/dl) | 205.8 ± 225.1 | 204.4 ± 193.5 | 192.0 ± 170.9 | 56.5 |
A1C (%) | 7.5 ± 1.8 | 7.7 ± 1.9 | 7.6 ± 1.8 | 54.5 |
MDRD eGFR truncated at 90 | 71.2 ± 20.1 | 70.5 ± 20.9 | 69.8 ± 20.3 | 32.1 |
Zip median income ($) | 46,216.0 ± 14,888.5 | 43,786.1 ± 14,737.8 | 43,477.7 ± 14,583.6 | 0.1 |
Patients with CAD | ||||
Age (years) | 68.8 ± 11.2 | 70.3 ± 10.8 | 71.2 ± 10.3 | 0 |
BMI (kg/m2) | 30.2 ± 6.0 | 29.9 ± 6.0 | 30.3 ± 6.4 | 41.2 |
Systolic blood pressure (mmHg) | 133.4 ± 21.4 | 130.6 ± 22.1 | 132 ± 23.7 | 12.6 |
Diastolic blood pressure (mmHg) | 73.3 ± 11.7 | 71.6 ± 11.6 | 71.9 ± 11.7 | 12.7 |
HDL (mg/dl) | 43.7 ± 12.9 | 43.4 ± 13.2 | 44.2 ± 14.4 | 34.0 |
LDL (mg/dl) | 90.2 ± 35.6 | 93.9 ± 39.8 | 96.0 ± 36.7 | 35.0 |
Triglycerides (mg/dl) | 194.8 ± 256.2 | 203.6 ± 195.0 | 191.5 ± 191.0 | 35.0 |
A1C (%) | 7.3 ± 1.4 | 7.5 ± 1.6 | 7.3 ± 1.5 | 44.1 |
MDRD eGFR truncated at 90 | 64.9 ± 20.9 | 66.5 ± 20.9 | 62.7 ± 21.1 | 17.9 |
Zip median income ($) | 47,551.4 ± 15,925.4 | 44,756.9 ± 15,225.5 | 44,871.9 ± 15,716.3 | 0.1 |
Data are means ± SD or percent. eGFR, estimated glomerular filtration rate; MDRD, Modification of Diet in Renal Disease.